Gastroesophageal Reflux Disease Management

Initial Treatment Approach

The American Gastroenterological Association recommends initiating a 4- to 8-week trial of single-dose proton pump inhibitor (PPI) therapy taken 30-60 minutes before a meal for patients presenting with typical GERD symptoms without alarm features 1, 2
If inadequate response occurs after 4-8 weeks, the American College of Gastroenterology suggests escalating to twice-daily PPI dosing or switching to a more potent formulation 1, 2
Once symptoms are controlled, the American Gastroenterological Association recommends tapering to the lowest effective dose for maintenance 1, 2

The American Academy of Pediatrics recommends omeprazole as the preferred PPI for children with GERD due to superior efficacy over H2RAs and FDA approval down to age 2 years 4
The American Academy of Pediatrics suggests starting with lifestyle modifications (smaller frequent feedings, thickened formula, positioning) before pharmacotherapy 3, 4
If pharmacotherapy is needed, the American Academy of Pediatrics recommends omeprazole 0.7-3.3 mg/kg/day as more effective than famotidine for symptom relief and healing erosive esophagitis 4

The American College of Gastroenterology recommends performing objective testing (endoscopy and pH monitoring off PPI) to confirm GERD diagnosis before further escalation if symptoms persist despite twice-daily PPI therapy 1, 2
The American Thoracic Society suggests evaluating for antireflux surgery if confirmed pathologic GERD with adequate esophageal peristalsis 5, 1

The American Gastroenterological Association advises avoiding empiric long-term PPI therapy without objective confirmation of GERD diagnosis 1, 2
The American College of Chest Physicians recommends lifestyle modifications (weight loss, head of bed elevation, avoiding meals within 3 hours of bedtime) to accompany pharmacotherapy 5, 2
The American College of Chest Physicians suggests that for chronic cough attributed to GERD, intensive medical therapy including PPI, dietary modifications, and prokinetic agents may be needed, with omeprazole 40 mg twice daily used in refractory cases 6, 5